NUCHAL TRANSLUCENCY CANNOT BE USED AS A
โ
L. H. KORNMAN; L. P. MORSSINK; J. R. BEEKHUIS; B. T. H. M. DE WOLF; M. P. HERING
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 732 KB
We decided to assess the practicability of introducing nuchal translucency (NT) measurements as a screening programme for fetal Down's syndrome in the first trimester of pregnancy, within the population of women who receive ultrasound examinations in our department. Over a l-year period, measurement